Fig. 2From: Genome-wide DNA methylation signature predict clinical benefit of bevacizumab in non-small cell lung cancerFunctional enrichment analysis of survival-related host genes of promoter-associated DMRs. A. The top 20 enriched terms in GO analysis colored by P value. B. Network of GO enriched terms colored by cluster ID. Circles with different colors indicated membership in different GO term, and lines between them indicated the connection between different terms. C. The top 20 enriched pathways colored by P value. D. Network of pathways colored by cluster ID. Circles with different colors indicated membership in different pathways, and lines between them indicated the connection between different terms pathwaysBack to article page